A lay prescription for tailor-made drugs -: focus group reflections on pharmacogenomics

被引:30
作者
Almarsdóttir, AB
Björnsdóttir, I
Traulsen, JM
机构
[1] Univ Iceland, Fac Pharm, IS-107 Reykjavik, Iceland
[2] Pharmaceut Soc Iceland, IS-172 Seltjarnarnes, Iceland
[3] Pharmaceut Univ Denmark, Dept Social Pharm, DK-1200 Copenhagen O, Denmark
关键词
pharmacogenomics; lay perspectives; pharmaceutical R&D; genetics; focus groups; Iceland;
D O I
10.1016/j.healthpol.2004.08.010
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study explores the lay view of pharmaceutical research and development-specifically pharmacogenomics. Forty-two persons participated in eight focus groups in Iceland. Participants were asked to comment on a future scenario consisting of predictions made by researchers concerning the consequences of the Human Genome Project over the next 40 years, and asked to give advice to politicians and the pharmaceutical industry. A dominating theme in the focus groups was the expectation that drugs developed based on pharmacogenomics will be more expensive than conventional mass produced drugs and concerns were voiced that this new technology Would lead to inequalities locally and globally. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:233 / 241
页数:9
相关论文
共 30 条
[1]  
Almarsdóttir AB, 2000, INT J HEALTH PLAN M, V15, P149
[2]  
[Anonymous], 1999, DEV FOCUS GROUP RES
[3]  
[Anonymous], 2000, FORUM QUALITATIVE SO
[4]   A seat at the table: Membership in federal advisory committees evaluating public policy in genetics [J].
Ard, CF ;
Natowicz, MR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2001, 91 (05) :787-790
[5]   Informed lay preferences for delivery of racially varied pharmacogenomics [J].
Bevan, JL ;
Lynch, JA ;
Dubriwny, TN ;
Harris, TM ;
Achter, PJ ;
Reeder, AL ;
Condit, CM .
GENETICS IN MEDICINE, 2003, 5 (05) :393-399
[6]   CONSULTING THE PUBLIC ABOUT HEALTH-SERVICE PRIORITIES [J].
BOWIE, C ;
RICHARDSON, A ;
SYKES, W .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7013) :1155-1158
[7]  
CHRISTENSEN BM, 1999, QUALITATIVE ANAL WIN
[8]   Ethical, legal, and social implications of genomic medicine [J].
Clayton, EW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :562-569
[9]   Attitudinal barriers to delivery of race-targeted pharmacogenomics among informed lay persons [J].
Condit, C ;
Templeton, A ;
Bates, BR ;
Bevan, JL ;
Harris, TM .
GENETICS IN MEDICINE, 2003, 5 (05) :385-392
[10]   The economics of gene therapy and of pharmacogenetics [J].
Danzon, P ;
Towse, A .
VALUE IN HEALTH, 2002, 5 (01) :5-13